IRBM Articles and White papers Archivi

Under the microscope: Exploring phage display technologies for drug discovery and early development

IRBM Articles and White papers

With over 20 years’ of expertise in phage display, IRBM applies its extensive peptide and antibody libraries to discover lead therapeutic candidates.

IRBM’s Elisabetta Bianchi talks about peptide chemistry

IRBM Articles and White papers

This feature article in Chemistry Today, highlights our peptide chemistry team’s extensive expertise in peptide and macrocyclic drug discovery in a range of therapeutic areas and with an impressive track record in the clinic.

The Power of NMR in Drug Discovery

IRBM Articles and White papers

Structural biology (SB) provides a critical drug discovery and development tool for accurately identifying and understanding the structure of a target. Alessandro Piai, PhD, Principal Research Scientist at IRBM, describes the company’s expertise in nuclear magnetic resonance (NMR) and how it can be leveraged to accelerate the identification of molecules for progression to the clinic.

Carlo Toniatti, Chief Scientific Officer Of IRBM

IRBM CSO Carlo Toniatti on the Evolving CRO Role in Drug Development, Emerging Approaches in Oncology & the Potential of AI

IRBM Articles and White papers

Source: Pharma Boardroom

Interview with IRBM’s Dr Maria Veneziano on pharmacokinetic studies

IRBM Articles and White papers

At IRBM we are passionate about science, and love talking about what we do to advance drug discovery. One of our scientists, Dr Maria Veneziano, has been interviewed by the International Journal of Pharmacokinetics (IJP), about her extensive experience working on pharmacokinetic studies.

Source: International Journal of Pharmacokinetics (IJP)

MEET THE TEAM